PDE10A and stroke disorder: These findings were complemented by another study investigating pharmacological PDE10A deactivation in an experimental model of striatal stroke (middle cerebral artery occlusion, MCAO model) that showed decreased infarct volume, brain edema, blood–brain barrier leakage, and disseminated neuronal injury [15].